Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial
{{output}}
Background: Maridebart cafraglutide (known as MariTide) is a long-acting peptide-antibody conjugate that combines glucagon-like peptide-1 receptor agonism and glucose-dependent insulinotropic polypeptide receptor antagonism and t... ...
